Publication | Closed Access

Prevalence of BRCA1/2 mutations in sporadic breast/ovarian cancer patients and identification of a novel de novo BRCA1 mutation in a patient diagnosed with late onset breast and ovarian cancer: implications for genetic testing

Brca1 MutationBreast OncologyMedicineBrca1/2 MutationsGenetic EpidemiologyPathologyGynecologyLate Onset BreastCancer GenomicsBreast CancerCancer GeneticsMolecular DiagnosticsOncologyRadiation OncologyPublic HealthOvarian Cancer